Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses

AnnaMaria De Filippo, Robert J. Binder, Chiara Camisaschi, Valeria Beretta, Flavio Arienti, Antonello Villa, Pamela Della Mina, Giorgio Parmiani, Licia Rivoltini, Chiara Castelli

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Glucose-regulated stress protein gp96 is known to be involved in the host response to pathogens and to cancer. Our study explored the relationships between gp96 and human blood plasmacytoid dendritic cells (pDC) and proved that gp96 directly targets pDC by a receptor-dependent interaction. Competition studies identified CD91 as a gp96 receptor on pDC, and laser confocal imaging indicated that CD91 triggering was followed by gp96 endocytosis and trafficking into early endosomes and later into the endoplasmic reticulum compartment. Using two alternative Abs, we showed that human blood pDC reproducibly expressed CD91, although different levels of expression were detectable among the analyzed donors. Moreover, CpG-matured pDC displayed CD91 receptor up-regulation that correlated with an increased gp96 binding. Functionally, gp96-pDC interaction activated the NF-κB pathway, leading to the nuclear translocation of the NF-κB complex. gp96-treated pDC maintained an immature phenotype, while they down-modulated the release of IL-8, suggesting an anti-inflammatory role of this pathway, and they strongly up-regulated the cell surface expression of the gp96 receptor CD91. CpG-matured or gp96-treated pDC, expressing high levels of the gp96 receptor CD91, antagonized the gp96-induced activation of monocyte-derived dendritic cells in terms of cell surface phenotype and cytokine production. Altogether, these results suggest that gp96-pDC interaction might represent an active mechanism controlling the strength of the immune response to free, extracellular available gp96; this mechanism could be particularly relevant in wounds and chronic inflammation.

Original languageEnglish
Pages (from-to)6525-6535
Number of pages11
JournalJournal of Immunology
Volume181
Issue number9
Publication statusPublished - Nov 1 2008

Fingerprint

Dendritic Cells
Cell Communication
Phenotype
Endosomes
Heat-Shock Proteins
Endocytosis
Interleukin-8
Endoplasmic Reticulum
Monocytes
Lasers
Anti-Inflammatory Agents
Up-Regulation
Cytokines
Inflammation
Wounds and Injuries

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

De Filippo, A., Binder, R. J., Camisaschi, C., Beretta, V., Arienti, F., Villa, A., ... Castelli, C. (2008). Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses. Journal of Immunology, 181(9), 6525-6535.

Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses. / De Filippo, AnnaMaria; Binder, Robert J.; Camisaschi, Chiara; Beretta, Valeria; Arienti, Flavio; Villa, Antonello; Della Mina, Pamela; Parmiani, Giorgio; Rivoltini, Licia; Castelli, Chiara.

In: Journal of Immunology, Vol. 181, No. 9, 01.11.2008, p. 6525-6535.

Research output: Contribution to journalArticle

De Filippo, A, Binder, RJ, Camisaschi, C, Beretta, V, Arienti, F, Villa, A, Della Mina, P, Parmiani, G, Rivoltini, L & Castelli, C 2008, 'Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses', Journal of Immunology, vol. 181, no. 9, pp. 6525-6535.
De Filippo A, Binder RJ, Camisaschi C, Beretta V, Arienti F, Villa A et al. Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses. Journal of Immunology. 2008 Nov 1;181(9):6525-6535.
De Filippo, AnnaMaria ; Binder, Robert J. ; Camisaschi, Chiara ; Beretta, Valeria ; Arienti, Flavio ; Villa, Antonello ; Della Mina, Pamela ; Parmiani, Giorgio ; Rivoltini, Licia ; Castelli, Chiara. / Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses. In: Journal of Immunology. 2008 ; Vol. 181, No. 9. pp. 6525-6535.
@article{5c6251c670e34b139924d5b1d2b1676a,
title = "Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses",
abstract = "Glucose-regulated stress protein gp96 is known to be involved in the host response to pathogens and to cancer. Our study explored the relationships between gp96 and human blood plasmacytoid dendritic cells (pDC) and proved that gp96 directly targets pDC by a receptor-dependent interaction. Competition studies identified CD91 as a gp96 receptor on pDC, and laser confocal imaging indicated that CD91 triggering was followed by gp96 endocytosis and trafficking into early endosomes and later into the endoplasmic reticulum compartment. Using two alternative Abs, we showed that human blood pDC reproducibly expressed CD91, although different levels of expression were detectable among the analyzed donors. Moreover, CpG-matured pDC displayed CD91 receptor up-regulation that correlated with an increased gp96 binding. Functionally, gp96-pDC interaction activated the NF-κB pathway, leading to the nuclear translocation of the NF-κB complex. gp96-treated pDC maintained an immature phenotype, while they down-modulated the release of IL-8, suggesting an anti-inflammatory role of this pathway, and they strongly up-regulated the cell surface expression of the gp96 receptor CD91. CpG-matured or gp96-treated pDC, expressing high levels of the gp96 receptor CD91, antagonized the gp96-induced activation of monocyte-derived dendritic cells in terms of cell surface phenotype and cytokine production. Altogether, these results suggest that gp96-pDC interaction might represent an active mechanism controlling the strength of the immune response to free, extracellular available gp96; this mechanism could be particularly relevant in wounds and chronic inflammation.",
author = "{De Filippo}, AnnaMaria and Binder, {Robert J.} and Chiara Camisaschi and Valeria Beretta and Flavio Arienti and Antonello Villa and {Della Mina}, Pamela and Giorgio Parmiani and Licia Rivoltini and Chiara Castelli",
year = "2008",
month = "11",
day = "1",
language = "English",
volume = "181",
pages = "6525--6535",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "9",

}

TY - JOUR

T1 - Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses

AU - De Filippo, AnnaMaria

AU - Binder, Robert J.

AU - Camisaschi, Chiara

AU - Beretta, Valeria

AU - Arienti, Flavio

AU - Villa, Antonello

AU - Della Mina, Pamela

AU - Parmiani, Giorgio

AU - Rivoltini, Licia

AU - Castelli, Chiara

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Glucose-regulated stress protein gp96 is known to be involved in the host response to pathogens and to cancer. Our study explored the relationships between gp96 and human blood plasmacytoid dendritic cells (pDC) and proved that gp96 directly targets pDC by a receptor-dependent interaction. Competition studies identified CD91 as a gp96 receptor on pDC, and laser confocal imaging indicated that CD91 triggering was followed by gp96 endocytosis and trafficking into early endosomes and later into the endoplasmic reticulum compartment. Using two alternative Abs, we showed that human blood pDC reproducibly expressed CD91, although different levels of expression were detectable among the analyzed donors. Moreover, CpG-matured pDC displayed CD91 receptor up-regulation that correlated with an increased gp96 binding. Functionally, gp96-pDC interaction activated the NF-κB pathway, leading to the nuclear translocation of the NF-κB complex. gp96-treated pDC maintained an immature phenotype, while they down-modulated the release of IL-8, suggesting an anti-inflammatory role of this pathway, and they strongly up-regulated the cell surface expression of the gp96 receptor CD91. CpG-matured or gp96-treated pDC, expressing high levels of the gp96 receptor CD91, antagonized the gp96-induced activation of monocyte-derived dendritic cells in terms of cell surface phenotype and cytokine production. Altogether, these results suggest that gp96-pDC interaction might represent an active mechanism controlling the strength of the immune response to free, extracellular available gp96; this mechanism could be particularly relevant in wounds and chronic inflammation.

AB - Glucose-regulated stress protein gp96 is known to be involved in the host response to pathogens and to cancer. Our study explored the relationships between gp96 and human blood plasmacytoid dendritic cells (pDC) and proved that gp96 directly targets pDC by a receptor-dependent interaction. Competition studies identified CD91 as a gp96 receptor on pDC, and laser confocal imaging indicated that CD91 triggering was followed by gp96 endocytosis and trafficking into early endosomes and later into the endoplasmic reticulum compartment. Using two alternative Abs, we showed that human blood pDC reproducibly expressed CD91, although different levels of expression were detectable among the analyzed donors. Moreover, CpG-matured pDC displayed CD91 receptor up-regulation that correlated with an increased gp96 binding. Functionally, gp96-pDC interaction activated the NF-κB pathway, leading to the nuclear translocation of the NF-κB complex. gp96-treated pDC maintained an immature phenotype, while they down-modulated the release of IL-8, suggesting an anti-inflammatory role of this pathway, and they strongly up-regulated the cell surface expression of the gp96 receptor CD91. CpG-matured or gp96-treated pDC, expressing high levels of the gp96 receptor CD91, antagonized the gp96-induced activation of monocyte-derived dendritic cells in terms of cell surface phenotype and cytokine production. Altogether, these results suggest that gp96-pDC interaction might represent an active mechanism controlling the strength of the immune response to free, extracellular available gp96; this mechanism could be particularly relevant in wounds and chronic inflammation.

UR - http://www.scopus.com/inward/record.url?scp=58749109185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58749109185&partnerID=8YFLogxK

M3 - Article

C2 - 18941243

AN - SCOPUS:58749109185

VL - 181

SP - 6525

EP - 6535

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 9

ER -